Emma L. McInturff

Emma L. McInturff

Auto-generated profile, based on publicly available information

Emma L. McInturff

Groton Laboratories, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2019 in Organic Process Research & Development
Verified
Journal Article
Open access
SMSteven M. Mennen
Steven M. Mennen
CACarolina Alhambra
Carolina Alhambra
CAC. Liana Allen
C. Liana Allen
MBMario Barberis
Mario Barberis
SBSimon Berritt
Simon Berritt
MZMatthew Allen Zajac
Matthew Allen Zajac
High-throughput experimentation (HTE) has revolutionized the pharmaceutical industry, most notably allowing for rapid screening of compound libraries against therapeutic targets. The last decade has also witnessed the extension of HTE principles toward the realm of small-molecule process chemistry. Today, most major pharmaceutical companies have created dedicated HTE groups within their process development teams, invested in automation technology to accelerate screening, or both. The industry’s commitment to accelerating process development has led to rapid innovations in the HTE space. This review will deliver an overview of the latest best practices currently taking place within our teams in process chemistry by sharing frequently-studied transformations, our perspective for the next several years in the field, and manual and automated tools to enable experimentation. A series of case studies are presented to exemplify state-of-the-art workflows developed within our laboratories.

27 April 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AFAndrew C. Flick
Andrew C. Flick
CLCarolyn A. Leverett
Carolyn A. Leverett
HDHong Xia Ding
Hong Xia Ding
EMEmma L McInturff
Emma L McInturff
SFSarah J. Fink
Sarah J. Fink
COChristopher J. O’donnell
Christopher J. O’donnell

30 March 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AFAndrew C. Flick
Andrew C. Flick
CLCarolyn A. Leverett
Carolyn A. Leverett
HDHong X. Ding
Hong X. Ding
EMEmma McInturff
Emma McInturff
SFSarah J. Fink
Sarah J. Fink
COChristopher J. O’dOnnell
Christopher J. O’dOnnell

14 July 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AFAndrew C. Flick
Andrew C. Flick
CLCarolyn A. Leverett
Carolyn A. Leverett
HDHong X. Ding
Hong X. Ding
EMEmma L. McInturff
Emma L. McInturff
SFSarah J. Fink
Sarah J. Fink
COChristopher J. O’dOnnell
Christopher J. O’dOnnell

29 March 2023 in ACS Central Science
Verified
Journal Article
Open access
CAChristophe Allais
Christophe Allais
CCChristina G. Connor
Christina G. Connor
NDNga M. Do
Nga M. Do
SKSamir Kulkarni
Samir Kulkarni
JLJohnny W. Lee
Johnny W. Lee
RWR. Matt Weekly
R. Matt Weekly
The advancement of nirmatrelvir, the active ingredient in Paxlovid, from discovery to emergency use authorization was achieved in just 17 months, requiring an unprecedented rate of chemical process development.

15 March 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SFScott P. France
Scott P. France
ELErick A. Lindsey
Erick A. Lindsey
EMEmma L. McInturff
Emma L. McInturff
SBSimon Berritt
Simon Berritt
DCDaniel W. Carney
Daniel W. Carney
RWRebecca B. Watson
Rebecca B. Watson